COVID後のサプライチェーン管理の未来

Panelists discuss how things have changed in clinical supply chain as a result of the pandemic.

In 2020年6月, we hosted thought-provoking panel discussion with Top 25 Pharma sponsors Biogen and GSK, and vendors, PCI Clinical Services and Suvoda, to discuss how new trends in the clinical supply chain will shape the way clinical operations will be run in the future. Panelists examined how emergent trial designs and supply chain strategies can be successfully implemented to address clinical supply chain challenges amidst COVID. Panelists spoke about what clinical operations trends will remain or arise as our society moves beyond the impact of COVID-19.

この事例から得られる情報

  • What trends addressing current supply chain challenges will remain a part of the clinical landscape moving forward?
  • How will trial designs shift and how will supply chain strategies change as a result?
  • Direct-to-patient shipment – where does it work, how to navigate its associated challenges?
  • What are some ways that vendors can collaborate more effectively to ensure treatments will continue to quickly advance?
公開 2020年6月

 

Powered by Translations.com GlobalLink OneLink Software